CY2025 Q2
| Company | Value | End Date | SEC Filing |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | $346,000,000.00 | 2025-06-30 | View |
| 1st FRANKLIN FINANCIAL CORPORATION | $253,938,808.00 | 2025-06-30 | View |
| HUMANA INC | $431,000,000.00 | 2025-06-30 | View |
| PACKAGING CORP OF AMERICA | $75,600,000.00 | 2025-06-30 | View |
| PFIZER INC | $1,000,000.00 | 2025-06-29 | View |
| PITNEY BOWES INC | $146,572,000.00 | 2025-06-30 | View |
| RPM INTERNATIONAL INC/DE/ | $20,200,000.00 | 2025-05-31 | View |
| Micron Technology, Inc. | $1,402,000,000.00 | 2025-05-29 | View |
| Paychex, Inc. | $0.00 | 2025-05-31 | View |
| MITEK SYSTEMS, INC. | $8,304,000.00 | 2025-06-30 | View |
| Starbucks Corporation | $232,000,000.00 | 2025-06-29 | View |
| HCA Healthcare, Inc. | $531,000,000.00 | 2025-06-30 | View |
| IONIS PHARMACEUTICALS, INC. | $718,346,000.00 | 2025-06-30 | View |
| ASURE SOFTWARE, INC. | $59,793,000.00 | 2025-06-30 | View |
| VERICEL CORPORATION | $47,400,000.00 | 2025-06-30 | View |
| NEKTAR THERAPEUTICS | $0.00 | 2025-06-30 | View |
| NEUROCRINE BIOSCIENCES, INC. | $873,800,000.00 | 2025-06-30 | View |
| ERIE INDEMNITY COMPANY | $1,048,584,000.00 | 2025-06-30 | View |
| Azenta, Inc. | $222,168,000.00 | 2025-06-30 | View |
| BioMarin Pharmaceutical Inc | $508,592,000.00 | 2025-06-30 | View |
| F5, INC. | $0.00 | 2025-06-30 | View |
| CYTOKINETICS, INCORPORATED | $178,201,000.00 | 2025-06-30 | View |
| Akamai Technologies, Inc | $566,645,000.00 | 2025-06-30 | View |
| ALLIANCE RESOURCE PARTNERS LP | $13,046,000.00 | 2025-06-30 | View |
| NiSource Inc. | $144,900,000.00 | 2025-06-30 | View |
| AXCELIS TECHNOLOGIES INC | $31,114,000.00 | 2025-06-30 | View |
| Tapestry, Inc. | $0.00 | 2025-06-28 | View |
| GARMIN LTD | $1,285,887,000.00 | 2025-06-28 | View |
| LIQUIDMETAL TECHNOLOGIES INC | $8,267,000.00 | 2025-06-30 | View |
| ELEVANCE HEALTH, INC. | $1,087,000,000.00 | 2025-06-30 | View |
| CARDIFF ONCOLOGY, INC. | $9,792,000.00 | 2025-06-30 | View |
| LegalZoom.com, Inc. | $0.00 | 2025-06-30 | View |
| Turning Point Brands, Inc. | $6,214,000.00 | 2025-06-30 | View |
| ALLOT LTD. | $21,672,000.00 | 2025-06-30 | View |
| ANAPTYSBIO, INC | $27,996,000.00 | 2025-06-30 | View |
| ETSY, INC | $126,640,000.00 | 2025-06-30 | View |
| SERVICENOW, INC. | $4,655,000,000.00 | 2025-06-30 | View |
| HubSpot, Inc. | $191,251,000.00 | 2025-06-30 | View |
| Olo Inc. | $51,063,000.00 | 2025-06-30 | View |
| Zevra Therapeutics, Inc. | $15,089,000.00 | 2025-06-30 | View |
| AGIOS PHARMACEUTICALS, INC. | $400,467,000.00 | 2025-06-30 | View |
| ADAPTIVE BIOTECHNOLOGIES CORPORATION | $24,100,000.00 | 2025-06-30 | View |
| MACOM Technology Solutions Holdings, Inc. | $416,991,000.00 | 2025-07-04 | View |
| ULTRAGENYX PHARMACEUTICAL INC. | $51,454,000.00 | 2025-06-30 | View |
| Alkermes plc. | $38,124,000.00 | 2025-06-30 | View |
| Aclaris Therapeutics, Inc. | $81,084,000.00 | 2025-06-30 | View |
| Oscar Health, Inc. | $1,845,884,000.00 | 2025-06-30 | View |
| Acumen Pharmaceuticals, Inc. | $22,797,000.00 | 2025-06-30 | View |
| MARCUS & MILLICHAP, INC. | $110,206,000.00 | 2025-06-30 | View |
| Atea Pharmaceuticals, Inc. | $0.00 | 2025-06-30 | View |
| Inspire Medical Systems, Inc. | $109,830,000.00 | 2025-06-30 | View |
| Caribou Biosciences, Inc. | $0.00 | 2025-06-30 | View |
| Stoke Therapeutics, Inc. | $107,256,000.00 | 2025-06-30 | View |
| BABCOCK & WILCOX ENTERPRISES, INC | $3,000,000.00 | 2025-06-30 | View |
| UroGen Pharma Ltd. | $4,632,000.00 | 2025-06-30 | View |
| FULGENT GENETICS, INC. | $484,471,000.00 | 2025-06-30 | View |
| Moderna, Inc. | $2,374,000,000.00 | 2025-06-30 | View |
| PRAXIS PRECISION MEDICINES, INC. | $145,369,000.00 | 2025-06-30 | View |
| Arcus Biosciences, Inc. | $16,000,000.00 | 2025-06-30 | View |
| SEER, INC. | $53,426,000.00 | 2025-06-30 | View |
| GOSSAMER BIO, INC. | $0.00 | 2025-06-30 | View |
| Allogene Therapeutics, Inc. | $29,510,000.00 | 2025-06-30 | View |
| Mirum Pharmaceuticals, Inc. | $17,112,000.00 | 2025-06-30 | View |
| CLIMB BIO, INC. | $102,702,000.00 | 2025-06-30 | View |
| CoreWeave, Inc. | $0.00 | 2025-06-30 | View |
| DOORDASH, INC. | $725,000,000.00 | 2025-06-30 | View |
| ORIC PHARMACEUTICALS, INC. | $45,216,000.00 | 2025-06-30 | View |
| CLOVER HEALTH INVESTMENTS, CORP. /DE | $175,470,000.00 | 2025-06-30 | View |
| Royalty Pharma plc | $271,900,000.00 | 2025-06-30 | View |
| NAUTILUS BIOTECHNOLOGY, INC. | $31,636,000.00 | 2025-06-30 | View |
| Orchestra BioMed Holdings, Inc. | $1,300,000.00 | 2025-06-30 | View |
| Abacus Global Management, Inc. | $3,287,463.00 | 2025-06-30 | View |
| KYMERA THERAPEUTICS, INC. | $297,629,000.00 | 2025-06-30 | View |
| TOURMALINE BIO, INC. | $17,184,000.00 | 2025-06-30 | View |
| ENERGY VAULT HOLDINGS, INC. | $1,418,000.00 | 2025-06-30 | View |
| RIGETTI COMPUTING, INC. | $145,903,000.00 | 2025-06-30 | View |
| NET Power Inc. | $68,913,000.00 | 2025-06-30 | View |
| CANTOR EQUITY PARTNERS, INC. | $104,166,637.00 | 2025-06-30 | View |
| AN2 Therapeutics, Inc. | $8,301,000.00 | 2025-06-30 | View |
| Pagaya Technologies Ltd. | $848,542,000.00 | 2025-06-30 | View |
| Lexeo Therapeutics, Inc. | $19,613,000.00 | 2025-06-30 | View |
| Silvaco Group, Inc. | $0.00 | 2025-06-30 | View |
| CANTOR EQUITY PARTNERS III, INC. | $276,008,345.00 | 2025-06-30 | View |
| CANTOR EQUITY PARTNERS II, INC. | $241,485,028.00 | 2025-06-30 | View |
SEC Filings Explorer
Formalu provides easy access to SEC filings and reporting data
Most Recent Filings
2000 most recent SEC filings for the current official filing date
Browse By Company
All SEC filings and reported GAAP facts from 2010 to now for every company
Formalu's Securities and Exchange Commission Page
SEC forms, contact information and locations